These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15854021)

  • 1. Osteopontin in melanocytic lesions--a first step towards invasion?
    Sturm RA
    J Invest Dermatol; 2005 May; 124(5):xiv-xv. PubMed ID: 15854021
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteopontin expression correlates with melanoma invasion.
    Denhardt D
    J Invest Dermatol; 2005 May; 124(5):xvi-xviii. PubMed ID: 15854023
    [No Abstract]   [Full Text] [Related]  

  • 3. Osteopontin expression correlates with melanoma invasion.
    Zhou Y; Dai DL; Martinka M; Su M; Zhang Y; Campos EI; Dorocicz I; Tang L; Huntsman D; Nelson C; Ho V; Li G
    J Invest Dermatol; 2005 May; 124(5):1044-52. PubMed ID: 15854047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
    Serban ED; Farnetani F; Pellacani G; Constantin MM
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of melanoma precursor lesions.
    Wang Y; Rao U; Mascari R; Richards TJ; Panson AJ; Edington HD; Shipe-Spotloe JM; Donnelly SS; Kirkwood JM; Becker D
    Cell Growth Differ; 1996 Dec; 7(12):1733-40. PubMed ID: 8959342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dispelling the myth of the "benign hair sign" for melanoma.
    Scope A; Tabanelli M; Busam KJ; Rabinovitz H; Braun RP; Marghoob AA
    J Am Acad Dermatol; 2007 Mar; 56(3):413-6. PubMed ID: 17156892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in ERBB4 may have a minor role in melanoma pathogenesis.
    Manca A; Lissia A; Cossu A; Rubino C; Ascierto PA; Stanganelli I; Palmieri G
    J Invest Dermatol; 2013 Jun; 133(6):1685-7. PubMed ID: 23340734
    [No Abstract]   [Full Text] [Related]  

  • 8. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
    Fröhlich E; Mack AF; Garbe C; Klessen C
    Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratinocytes drive melanoma invasion in a reconstructed skin model.
    Van Kilsdonk JW; Bergers M; Van Kempen LC; Schalkwijk J; Swart GW
    Melanoma Res; 2010 Oct; 20(5):372-80. PubMed ID: 20700063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of osteopontin in the development and metastasis of melanoma.
    Zhao Y; Huang C
    Melanoma Res; 2021 Aug; 31(4):283-289. PubMed ID: 34039941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histopathological prognostic factors of malignant melanoma].
    Plótár V; Orosz Z; Tóth E; Szentirmay Z
    Magy Onkol; 2007; 51(1):39-46. PubMed ID: 17417674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine stimulation by osteopontin contributes to antiapoptotic signalling of melanocytes in dermal collagen.
    Geissinger E; Weisser C; Fischer P; Schartl M; Wellbrock C
    Cancer Res; 2002 Aug; 62(16):4820-8. PubMed ID: 12183442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutated ERBB4: a novel drug target in metastatic melanoma?
    Kurppa K; Elenius K
    Pigment Cell Melanoma Res; 2009 Dec; 22(6):708-10. PubMed ID: 19735458
    [No Abstract]   [Full Text] [Related]  

  • 15. Automatic measurement of melanoma depth of invasion in skin histopathological images.
    Xu H; Berendt R; Jha N; Mandal M
    Micron; 2017 Jun; 97():56-67. PubMed ID: 28346884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of monoacylglycerol lipase as a marker of tumour invasion and progression in malignant melanoma.
    Baba Y; Funakoshi T; Mori M; Emoto K; Masugi Y; Ekmekcioglu S; Amagai M; Tanese K
    J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):2038-2045. PubMed ID: 28681540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intra-epithelial melanocytic neoplasia (MIN), a new term proposed for dysplastic melanocytic lesions].
    Collina G
    Pathologica; 1997 Apr; 89(2):196-8. PubMed ID: 9411373
    [No Abstract]   [Full Text] [Related]  

  • 18. Biology of melanoma invasion and metastasis.
    Liotta LA; Guirguis R; Stracke M
    Pigment Cell Res; 1987; 1(1):5-15. PubMed ID: 3333834
    [No Abstract]   [Full Text] [Related]  

  • 19. [Unusual and unknown aspect of cutaneous malignant melanoma: minimal deviation malignant melanoma. Retrospective study of 45 cases].
    Mérot Y; Mihm MC
    Ann Dermatol Venereol; 1985; 112(4):325-36. PubMed ID: 4026131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi.
    Kittler H; Pehamberger H; Wolff K; Binder M
    J Am Acad Dermatol; 2000 Sep; 43(3):467-76. PubMed ID: 10954658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.